Literature DB >> 3785290

AAEE minimonograph #25: Single-fiber electromyography in myasthenia gravis.

D B Sanders, J F Howard.   

Abstract

Single-fiber electromyography (SFEMG) demonstrates abnormal jitter in virtually all (99%) patients with myasthenia gravis (MG). One muscle, the extensor digitorum communis, is abnormal in most patients with this disease, but to obtain the maximum diagnostic sensitivity, it may be necessary to examine other muscles, especially ones that are more involved clinically. There is no one muscle that will be more abnormal in every patient with MG. The muscle(s) to be tested must be selected based on the distribution of weakness in the individual patient. Abnormal jitter is also seen in diseases of nerve and muscle; these diseases must be excluded by other electrophysiologic and clinical examinations before diagnosing MG. If neuronal or myopathic disease is present, increased jitter does not indicate that MG is also present. However, if jitter is normal in a muscle with definite weakness, the weakness is not due to MG. When abnormal neuromuscular transmission has been demonstrated by repetitive nerve stimulation, the finding of abnormal jitter does not add to the diagnosis, though it may be useful in providing baseline values for comparison with the results of subsequent studies. SFEMG is most valuable clinically in the patient with suspected MG in whom other tests of neuromuscular transmission and antiacetylcholine receptor antibody titers are normal. Serial measurements of jitter can be useful in following the course of disease and in assessing the effect of treatment, but the results from these studies must always be interpreted in light of the overall clinical picture.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3785290     DOI: 10.1002/mus.880090904

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  12 in total

1.  The jitter in stimulated orbicularis oculi muscle: technique and normal values.

Authors:  J V Trontelj; A Khuraibet; M Mihelin
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-06       Impact factor: 10.154

2.  Immediate effects of intravenous IgG administration on peripheral blood B and T cells and polymorphonuclear cells in patients with myasthenia gravis.

Authors:  L Cook; J F Howard; J D Folds
Journal:  J Clin Immunol       Date:  1988-01       Impact factor: 8.317

3.  Ocular myasthenia: diagnostic value of single fibre EMG in the orbicularis oculi muscle.

Authors:  M Milone; M L Monaco; A Evoli; S Servidei; P Tonali
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-06       Impact factor: 10.154

4.  Sensitivity and specificity of single-fibre EMG in the diagnosis of ocular myasthenia varies accordingly to clinical presentation.

Authors:  Maria Pia Giannoccaro; Vitantonio Di Stasi; Corrado Zanesini; Vincenzo Donadio; Patrizia Avoni; Rocco Liguori
Journal:  J Neurol       Date:  2019-11-16       Impact factor: 4.849

5.  Ocular Myasthenia Gravis.

Authors:  Victoria S. Pelak; Steven L. Galetta
Journal:  Curr Treat Options Neurol       Date:  2001-07       Impact factor: 3.598

Review 6.  A practical guide to the recognition and management of myasthenia gravis.

Authors:  A Evoli; A P Batocchi; P Tonali
Journal:  Drugs       Date:  1996-11       Impact factor: 9.546

Review 7.  Ocular myasthenia gravis. A critical review of clinical and pathophysiological aspects.

Authors:  N Sommer; A Melms; M Weller; J Dichgans
Journal:  Doc Ophthalmol       Date:  1993       Impact factor: 2.379

8.  Clinical and electrophysiological evaluation of dysphagia in myasthenia gravis.

Authors:  C Ertekin; N Yüceyar; I Aydogdu
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-12       Impact factor: 10.154

9.  Electrophysiological Findings of Subclinical Lower Motor Neuron Involvement in Degenerative Upper Motor Neuron Diseases.

Authors:  Hava Özlem Dede; Nermin Görkem Şırın; Elif Kocasoy-Orhan; Halil Atilla Idrısoğlu; Mehmet Barış Baslo
Journal:  Noro Psikiyatr Ars       Date:  2019-08-16       Impact factor: 1.339

10.  Electrophysiological study in neuromuscular junction disorders.

Authors:  Ajith Cherian; Neeraj N Baheti; Thomas Iype
Journal:  Ann Indian Acad Neurol       Date:  2013-01       Impact factor: 1.383

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.